Editorial Policies

Focus and Scope

eISSN: 2312-0398

Nasopharyngeal Carcinoma has unique racial/ethnic and geographic distribution, and is endemic in Southeast Asia and East Africa and Arabia, with Guangdong province and Hong Kong reporting some of the highest incidences in the world. 

Journal of Nasopharyngeal Carcinoma is an international, peer-reviewed, open-access, online publication. This journal publishes original research paper, review, commentary, Letter to Editor and case report in all areas of nasopharyngeal carcinoma (NPC).  The main subject areas of Journal of Nasopharyngeal Carcinoma include, but are not limited to, prevention, etiology, genetics, epidemiology, pathology, therapy, prognosis of nasopharyngeal carcinoma. 

Asia Press is a professional Science, Technology and Medicine publisher, who owns rapid publication, Peer-Reviewed, Open Access Journals. Asia Press aims to promote “knowledge sharing”. As you know, the main barrier for free “knowledge sharing” is the cost of publishing and transfer. In order to encourage scholars and scientists to the max, and devote whole power to realize the aim of “knowledge sharing” and the benefit of “all” mankind, Asia Press performs a permanent policy of no charge for publication and access, and always open its door for authors worldwide.

 

Section Policies

Review

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Articles

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Case report

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Perspective

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Letter to the Editor

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Commentary

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Short Communication

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

The main subject areas of Journal of Nasopharyngeal Carcinoma include, but are not limited to, prevention, etiology, genetics, epidemiology, pathology, therapy, prognosis of nasopharyngeal carcinoma.
To be accepted for publication in Journal of nasopharyngeal carcinoma , research articles must satisfy the following criteria:
1.The study presents the results of primary scientific research.
2.Results reported have not been published elsewhere.
3.Experiments, statistics, and other analyses are performed to a high technical standard and are described in sufficient detail.
4.Conclusions are presented in an appropriate fashion and are supported by the data.
5.The article is presented in an intelligible fashion and is written in standard English.
6.The research meets all applicable standards for the ethics of experimentation and research integrity.
7.The article adheres to appropriate reporting guidelines and community standards for data availability.

 

Publication Frequency

JNPC is online peer-reviewed and open access for rapid publication.

 

Open Access Policy

Journal of nasopharyngeal carcinoma applies the Creative Commons Attribution License (CCAL) to all works we publish.Under the CCAL, authors retain ownership of the copyright for their article, but authors allow anyone to download, reuse, reprint, modify, distribute, and/or copy articles in Journal of nasopharyngeal carcinoma, so long as the original authors and source are cited.

 

Indexed

JNPC is indexed by
1. Crossref: http://www.crossref.org/
2. Committee on Publication Ethics: http://publicationethics.org/
3. Western Pacific Region Index Medicus (WPRIM) http://wprim.whocc.org.cn/local/jt15.jsp
4.Google Scholar
5.Index of Copernicus(IC)
6.AE Global Index (AEGI).

 

Conflict-of-Interest Statement, Statement of Informed Consent Human and Animal Rights

Conflict-of-Interest Statement
Statement of Informed Consent
Human and Animal Rights
Author Guidelines, which is found in about the Journal of Nasopharyngeal Carcinoma

Last Update: March 08, 2016
http://www.journalofnasopharyngealcarcinoma.org/

Conflict-of-Interest Statement
Authors are expected to disclose any commercial or other associations that might pose a conflict of interest in connection with the submitted article, especially Guideline articles, reports of clinical trials and reports on pharmaceutical products or medical devices. All funding sources supporting the work and the institutional or corporate affiliations of the authors should be acknowledged on the title page. Articles are considered for publication on the understanding that neither the article nor its essential substance has been or will be published elsewhere before appearing in the Journal of Nasopharyngeal Carcinoma. Abstracts and press reports published in connection with scientific meetings are not considered as publications. The authors should specifically confirm in their cover letter that there has been no ghost writing by anyone not named as a co-author of the manuscript.
Conflict of Interest Statement for Journal of Nasopharyngeal Carcinoma

SAMPLE FORM
I hereby disclose all of my conflicts of interest and other potentially conflicting interests, including specific financial interests and relationships and affiliations relevant to Journal of Nasopharyngeal Carcinoma (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or stock options, expert testimony, royalties, or patents filed, received, or pending). This applies to the past 5 years and the foreseeable future. I also agree that I will promptly notify the Editor in Chief in writing about any additional potential conflicts of interests that occur.
I agree that I will disqualify myself from reviewing, editing, or participating in editorial decisions about any Journal of Nasopharyngeal Carcinoma submission that deals with a matter in which either I or a member of my immediate family (ie, my spouse, domestic partner, or minor children) have direct financial interest or a competing financial interest (eg, employment or affiliation, grants or funding, consultancies, honoraria, stock ownership or stock options, expert testimony, royalties, or patents filed, received, or pending). This also applies to the past 5 years and the foreseeable future.
I also agree that I will not use any confidential information obtained from my activities with Journal of Nasopharyngeal Carcinoma to further my own or others financial interests.
_____________________________
Name (please print)
_____________________________
Signature
_____________________________
Date

Please list any potential conflicts of interest:
_____________________________
_____________________________
_____________________________

Statement of Informed Consent
Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify Individuals who provide writing assistance and disclose the funding source for this assistance. Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. When informed consent has been obtained it should be indicated in the published article.

Human and Animal Rights
Depending on the nature of the regarding research, manuscripts submitted for publication in the Journal of Nasopharyngeal Carcinoma must contain a statement to the effect that the concerning legally binding ethical standards have been met. Authors are required to check if any of the below statements applies to their submitted work and if necessary, to tick the relevant box and sign the form accordingly.
Reports of animal experiments must state that the "Principles of Laboratory Animal Care" (NIH publication No. 85- 23, revised 1985) were followed. Moreover authors may have to state that specific national laws (e.g., the current version of the German Law on the Protection of Animals) have been observed, too.
All human studies must state that they have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. The author hereby declares that the research documented in the submitted manuscript has been carried out in accordance with the above stated ethical standards.

 

Editorial Policies

Ethics and consent
Ethics approval
Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption). Further information and documentation to support this should be made available to the Editor on request. Manuscripts may be rejected if the Editor considers that the research has not been carried out within an appropriate ethical framework. In rare cases, the Editor may contact the ethics committee for further information.
Consent to participate
For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or legal guardian in the case of children under 16) and a statement to this effect should appear in the manuscript.
Research involving animals
Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. The Basel Declarationoutlines fundamental principles to adhere to when conducting research in animals and the International Council for Laboratory Animal Science (ICLAS) has also published ethical guidelines.
A statement detailing compliance with relevant guidelines (e.g. the revised Animals (Scientific Procedures) Act 1986 in the UK and Directive 2010/63/EU in Europe) and/or ethical approval (including the name of the ethics committee and the reference number where appropriate) must be included in the manuscript. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption and the reasons for the exemption). The Editor will take account of animal welfare issues and reserves the right to reject a manuscript, especially if the research involves protocols that are inconsistent with commonly accepted norms of animal research. In rare cases, the Editor may contact the ethics committee for further information.
For experimental studies involving client-owned animals, authors must also document informed consent from the client or owner and adherence to a high standard (best practice) of veterinary care.
Field studies and other non-experimental research on animals must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. A statement detailing compliance with relevant guidelines and/or appropriate permissions or licences must be included in the manuscript. We recommend that authors comply with the Convention on the Trade in Endangered Species of Wild Fauna and Flora and theIUCN Policy Statement on Research Involving Species at Risk of Extinction.

Clinical Trial Registration
The Asia Press defines a clinical trial as any research project that prospectively assigns people or a group of people to an intervention, with or without concurrent comparison or control groups, to study the cause-and-effect relationship between a health-related intervention and a health outcome. Health-related interventions are those used to modify a biomedical or health-related outcome; examples include drugs, surgical procedures, devices, behavioral treatments, educational programs, dietary interventions, quality improvement interventions, and process-of-care changes. Health outcomes are any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. The Asia Press does not define the timing of first patient enrollment, but best practice dictates registration by the time of first patient consent.
The Asia Press accepts registration in any registry that is a primary register of the WHO International Clinical Trials Registry Platform (ICTRP) or in ClinicalTrials.gov,
The purpose of clinical trial registration is to prevent selective publication and selective reporting of research outcomes, to prevent unnecessary duplication of research effort, to help patients and the public know what trials are planned or ongoing into which they might want to enroll, and to help give ethics review boards considering approval of new studies a view of similar work and data relevant to the research they are considering.

Corrections and retractions
Rarely, it may be necessary for Asia Press to publish corrections to, or retractions of, articles published in its journals, so as to maintain the integrity of the academic record.
Corrections to, or retractions of, published articles will be made by publishing an Erratum or a Retraction article, without altering the original article in any way other than to add a prominent link to the Erratum/Retraction article. The original article remains in the public domain and the subsequent Erratum or Retraction will be widely indexed. In the exceptional event that material is considered to infringe certain rights or is defamatory, we may have to remove that material from our site and archive sites.
Corrections
Changes to published articles that affect the interpretation and conclusion of the article, but do not fully invalidate the article, will, at the Editor(s)’ discretion, be corrected via publication of an Erratum that is indexed and linked to the original article.
Retractions
On rare occasions, when the scientific information in an article is substantially undermined, it may be necessary for published articles to be retracted. Asia Press will follow the COPE guidelines in such cases. Retraction articles are indexed and linked to the original article.

 

Advertising Policies for print and web publications

The Asia Press accepts nonprofit advertising in certain of its publications including (but not limited to) professional journals and web sites, meeting and convention publications, and direct-to-patient/consumer publications and web sites.